gemfibrozil has been researched along with Hyperinsulinism in 1 studies
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
Excerpt | Relevance | Reference |
---|---|---|
"We studied the effects of gemfibrozil on glucose and fatty acid metabolism in subjects with mild endogenous hypertriglyceridemia." | 9.08 | Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. ( Knudsen, P; Sane, T; Taskinen, MR; Vuorinen-Markkola, H; Yki-Järvinen, H, 1995) |
"We studied the effects of gemfibrozil on glucose and fatty acid metabolism in subjects with mild endogenous hypertriglyceridemia." | 5.08 | Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. ( Knudsen, P; Sane, T; Taskinen, MR; Vuorinen-Markkola, H; Yki-Järvinen, H, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sane, T | 1 |
Knudsen, P | 1 |
Vuorinen-Markkola, H | 1 |
Yki-Järvinen, H | 1 |
Taskinen, MR | 1 |
1 trial available for gemfibrozil and Hyperinsulinism
Article | Year |
---|---|
Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.
Topics: Analysis of Variance; Apolipoprotein A-II; Blood Glucose; Cholesterol; Circadian Rhythm; Double-Blin | 1995 |